Alpa Laboratories share news, announcements and annual reports
NSE: ALPABSE: 532878Pharmaceuticals & BiotechnologySmall Cap
Alpa Laboratories Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Aug 2007
Last close ₹52.62up ₹0.42 (0.80%)BSE ₹52.60
Share price at the NSE close on 29 Oct 2026. Previous close ₹52.20.
29 Oct: open ₹51.00, high ₹53.20, low ₹51.00
52-week range of traded prices to 29 Oct 2026
₹46.10Low, 30 Mar 2026₹93.85High, 31 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹111 Cr2,659th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.59
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −1.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.01
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 5,88978.8% delivered
Alpa Laboratories board and management
24 filed, newest first.
Sep 2026
Jul 2026
Apr 2026
Feb 2026
Nov 2024
Aug 2023
Aug 2021
Mar 2021
Sep 2020
Sep 2017
30 Sep · Management
Jul 2016
15 Jul · Management
Apr 2016
Apr 2015
Jul 2014
17 Jul · Management
Ms. Monali Patel, Member of The Institute of Company Secretaries of India (ICSI) has been appointed as the Company Secretary and Compliance Officer.
Jun 2014
25 Jun · Management
Mr. Mayank Lashkari, Member of The Institute of Company Secretaries of India (ICSI) has resigned from the Company and hence is no longer the Company Secretary and Compliance Officer of the Company. Further, Mr. Bakulesh C. Shah, the Company's CFO has been appointed as the Compliance Officer till the time that the Company identifies and recruits a suitable person for the post of Company Secretary and Compliance Officer.
Mar 2014
20 Mar · Management
Mr. Mayank Lashkari, Member of The Institute of Company Secretaries of India (ICSI) has been appointed as of the Company Secretary and Compliance Officer and he has already assumed his responsibilities.
Jan 2011
17 Jan · Management
Mr. Devendra Baheti and Mr. Krishna Das Malani have been taken as an Independent Directors on the board of the company. Mr. Baheti has also been made the chairman of the audit committee. Also, the resignation of Mr. Sampat Lal Chaplot who was an Independent Director has been accepted and processed.
Sep 2008
10 Sep · Management
Mr. Sharad Chand Lunawat has been taken as an Independent Director on the board of the company. Also, the resignation of Mr. Ashok Das Gupta who was an Independent Director has been accepted and processed.
Jul 2008
29 Jul · Management
Mr. Kuldeep Singh Parwana has been taken as an Independent Director on the board of the company. Also, the resignation of Mr. Vijay Padaki who was an Independent Director has been accepted and processed.